SMITHBUCKLIN CORPORATION for ASTCT
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOLLY FORD | — |
Medicare/Medicaid MMM
- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOLLY FORD | — |
Medical/Disease Research/Clinical Labs MED
- Labor-HHS Appropriations - CAR-T Therapy clarification - S. 4440/H.R. 3521, the Clinical Trial Modernization Act - OMB Uniform Guidance Oversight
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOLLY FORD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.